文献速递临床试验与 GCP

治疗师辅助在线心理治疗创伤后应激障碍的随机对照试验(STOP-PTSD):试验方案

A randomised controlled trial of therapist-assisted online psychological therapies for posttraumatic stress disorder (STOP-PTSD): trial protocol.
PubMed 文献 · Trials · 2020-04-23

BACKGROUND: Over the last few decades, effective psychological treatments for posttraumatic stress disorder (PTSD) have been developed, but many patients are currently unable to access these treatments.…

要点

  • 首个比较聚焦创伤与非聚焦创伤治疗师辅助在线认知行为治疗PTSD的随机对照试验。
  • 主要结局为13周时PCL-5评估的PTSD症状严重程度。

核心结论

  • 该试验将首次比较聚焦创伤与非聚焦创伤的治疗师辅助在线认知行为治疗PTSD的疗效。

研究设计与样本

  • 单盲随机对照试验,比较iCT-PTSD、iStress-PTSD和13周等待组,嵌入过程研究。
  • 主要评估点为13周,另在6、26、39和65周进行随访评估。

关键数值与推荐

  • 主要结局为PCL-5测量的PTSD症状严重程度。
  • 次要PTSD测量包括CAPS-5和IES-R。
  • 其他评估包括PHQ-9、GAD-7、WHO-5、WSAS、QoL和ISI。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Over the last few decades, effective psychological treatments for posttraumatic stress disorder (PTSD) have been developed, but many patients are currently unable to access these treatments. There is initial evidence that therapist-assisted internet-based psychological treatments are effective for PTSD and may help increase access, but it remains unclear which of these treatments work best and are most acceptable to patients. This randomised controlled trial will compare a trauma-focussed and a nontrauma-focussed therapist-assisted cognitive behavioural Internet treatment for PTSD: Internet-delivered cognitive therapy for PTSD (iCT-PTSD) and internet-delivered stress management therapy (iStress-PTSD). METHODS/DESIGN: The study is a single-blind, randomised controlled trial comparing iCT-PTSD, iStress-PTSD and a 13-week wait-list condition, with an embedded process study. Assessors of treatment outcome will be blinded to trial arm. Two hundred and seventeen participants who meet DSM-5 criteria for PTSD will be randomly allocated by a computer programme to iCT-PTSD, iStress-PTSD or wait-list at a 3:3:1 ratio. The primary assessment point is at 13 weeks, and further assessments are taken at 6, 26, 39 and 65 weeks. The primary outcome measure is the severity of PTSD symptoms as measured by the PTSD Checklist for DSM-5 (PCL-5). Secondary measures of PTSD symptoms are the Clinician Administered PTSD Scale for DSM-5 (CAPS-5) and the Impact of Event Scale-Revised (IES-R). Other symptoms and well-being will be assessed with the Patient Health Questionnaire (PHQ-9), Generalised Anxiety Disorder Scale (GAD-7), WHO (Five) Well-Being Index, Work and Social Adjustment Scale (WSAS), Endicott Quality of Life Scale (QoL), and Insomnia Sleep Index (ISI). Health economics analyses will consider quality of life, productivity, health resource utilisation, employment status and state benefits, and treatment delivery costs. Process analyses will investigate candidate mediators and moderators of outcome. Patient experience will be assessed by interview and questionnaire. DISCUSSION: This study will be the first to compare the efficacy of a trauma-focussed and nontrauma-focussed therapist-assisted online cognitive behavioural treatment for people with posttraumatic stress disorder. TRIAL REGISTRATION: ISRCTN16806208. Registered prospectively on 5 January 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Ehlers A, Wild J, Warnock-Parkes E, et al. A randomised controlled trial of therapist-assisted online psychological therapies for posttraumatic stress disorder (STOP-PTSD): trial protocol. Trials. 2020. PMID: 32326954. doi:10.1186/s13063-020-4176-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。